FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of European ScreeningPort

European ScreeningPort receives funding for IMI Call4

11-Dec-2012 - European ScreeningPort is partner of an international consortium that has received confirmation of an over 20 million EURO grant award from the Innovative Medicine Initiative Joint Undertaking (IMI-JU). The programme “Kinetics for Drug Discovery – K4DD” involves 20 partners and is coordinated by ...

drug discovery kinetics

European ScreeningPort and Merck KGaA Sign Research Agreement

29-Oct-2010 - European ScreeningPort GmbHannounced that it has entered into an agreement with Merck KGaA as part of the New Drugs Fighting Neurological Diseases Consortium (NEU²). Under the agreement, the European ScreeningPort will use its expertise in order to establish a high-throughput screening assay for ...

high-throughput screening multiple sclerosis neurological diseases +1

New Screening Strategy for Epigenetic Targets: European ScreeningPort Forms Strategic Alliance with Hypha

26-Oct-2010 - Hypha Discovery Ltd and European ScreeningPort GmbH (ESP) announced a collaboration to evaluate Hypha’s MycoDiverseTM natural products library in ESP’s in-house epigenetic target assay panel. Currently, ESP provides access to Hypha’s MycoDiverseTM screening library to customers as part of its ...

assays asthma diseases +3

EUR 400,000 for New Malaria Drug

22-Dec-2009 - The Bernhard Nocht Institute for Tropical Medicine (BNI) has received funds of EUR 400,000 from the City of Hamburg for the development of a new anti-malaria drug. In cooperation with the European ScreeningPort, this may represent a crucial step in combating the malaria parasite. Dr Carsten ...

inhibitors Life Science technology transfer